Johns Hopkins ABX Guide
Palivizumab
INDICATIONS
FORMER U.S. FDA-LABELED INDICATIONS
FORMER U.S. FDA-LABELED INDICATIONS
- Palivizumab was voluntarily discontinued in the U.S. and is no longer manufactured, distributed, or available for purchase after December 31, 2025.
- Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease:
- History of premature birth (≤35 weeks gestational age) and those who are 6 months of age or younger at the beginning of the RSV season.
- History of bronchopulmonary dysplasia that required medical treatment within the previous 6 months, and who are 24 months of age or younger at the beginning of the RSV season.
- Hemodynamically significant congenital heart disease and those who are 24 months of age or younger at the beginning of the RSV season.
- Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease:
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 11, 2026
Citation
Tsai, Y. V, and Paul G Auwaerter. "Palivizumab." Johns Hopkins ABX Guide Johns Hopkins ABX Guide, The Johns Hopkins University, 2026. Johns Hopkins Guides, hopkinsguides.org/hopkins/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab.
Tsai YV, Auwaerter PG. Palivizumab. Johns Hopkins ABX Guide Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. https://hopkinsguides.org/hopkins/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab. Accessed October 13, 2026.
Tsai, Y. V., & Auwaerter, P. G. (2026). Palivizumab. In Johns Hopkins ABX Guide Johns Hopkins ABX Guide. The Johns Hopkins University. https://hopkinsguides.org/hopkins/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab
Tsai YV, Auwaerter PG. Palivizumab [Internet]. In: Johns Hopkins ABX Guide Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. [cited 2026 October 13]. Available from: https://hopkinsguides.org/hopkins/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Palivizumab
ID - 540413
A1 - Tsai,Y.,Pharm.D.
AU - Auwaerter,Paul,M.D.
Y1 - 2026/10/11/
BT - Johns Hopkins ABX Guide
UR - https://hopkinsguides.org/hopkins/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
